Patents by Inventor Yvonne Håkansson

Yvonne Håkansson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Gastric acid secretion inhibiting composition
    Patent number: 7785626
    Abstract: An oral pharmaceutical dosage form comprises pharmacologically effective amounts of an acid-susceptible proton pump inhibitor and an H2 receptor antagonist in combination with at least on pharmacologically acceptable excipient which causes a delayed release and/or an extended release of the proton pump inhibitor. The H2 receptor antagonist is included in the dosage form in such a way that it is rapidly released after administration. This dosage form is suitable for the treatment of conditions associated with an excessive secretion of gastric acid and provides a suitable combination of a rapid onset and a long-lasting duration of the effect. The invention also relates to a method for manufacturing such a dosage form and to a method for the treatment of conditions associated with the secretion of gastric acid.
    Type: Grant
    Filed: October 15, 2003
    Date of Patent: August 31, 2010
    Assignee: OREXO AB
    Inventors: Anders Pettersson, Christer Nyström, Yvonne Håkansson
  • Gastric acid secretion inhibiting composition
    Patent number: 7771747
    Abstract: An oral pharmaceutical dosage form comprises pharmacologically effective amounts of an acid-susceptible proton pump inhibitor and an H2 receptor antagonist in combination with at least on pharmacologically acceptable excipient which causes a delayed release and/or an extended release of the proton pump inhibitor. The H2 receptor antagonist is included in the dosage form in such a way that it is rapidly released after administration. This dosage form is suitable for the treatment of conditions associated with an excessive secretion of gastric acid and provides a suitable combination of a rapid onset and a long-lasting duration of the effect. The invention also relates to a method for manufacturing such a dosage form and to a method for the treatment of conditions associated with the secretion of gastric acid.
    Type: Grant
    Filed: October 10, 2006
    Date of Patent: August 10, 2010
    Assignee: Orexo AB
    Inventors: Anders Pettersson, Christer Nyström, Yvonne Håkansson